UniSA researchers win $1.3m to find better treatments for cancer

May 18, 2024

02 April 2024Three Centre for Cancer Biology (CCB) researchers from UniSA and SA Pathology have collectively been awarded more than $1.3 million to further vital research into bowel cancer, acute myeloid leukaemia (AML) and breast cancer. Compared to people diagnosed with late-onset bowel cancers, it is also more likely that the cancer will spread to other organs. Metastatic breast cancer is the most common cause of cancer-related related death in women and is helped by changes in the immediate environment that surrounds the breast cancer. “Breast cancer cells release chemicals that act on normal cells in their environment, which aid the cancer to spread to other organs. This project will focus on finding a way to block these chemicals that alter the environment, to stop breast cancer metastasis,” Dr Boyle says.

02 April 2024

Three Centre for Cancer Biology (CCB) researchers from UniSA and SA Pathology have collectively been awarded more than $1.3 million to further vital research into bowel cancer, acute myeloid leukaemia (AML) and breast cancer.

A team led by CCB scientist Professor Michael Samuel will investigate why people diagnosed with early-onset bowel cancer have a 50% chance of experiencing a relapse after surgery to remove the primary tumour. Compared to people diagnosed with late-onset bowel cancers, it is also more likely that the cancer will spread to other organs.

“At the moment we cannot predict whose tumours will return and whose won’t, resulting in some patients receiving unnecessary chemotherapy and others, who elect not to, relapsing,” Prof Samuel says.

“However, we have identified chemicals produced by tumours that affect the chances of cancer relapse. If we can block these from hijacking normal cells in their environment, this could be a new way of targeting bowel cancer.”

Prof Samuel’s team has been awarded $573,833 for this project, funded by Bowel Cancer Australia via Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme.

CCB leukaemia researcher Professor Richard D’Andrea will use a $599,392 grant from Cancer Australia to analyse genetic changes and improve precision medicine for children with acute myeloid leukaemia (AML).

Although children diagnosed with AML undergo aggressive chemotherapy, approximately 30% do not survive.

“It is now widely understood that the genes we are born with can affect our risk of developing AML and influence the response to treatment,” Dr D’Andrea says.

“Despite this knowledge, guidelines for doctors on how to best treat childhood AML patients based on their individual genetic profile are lacking. This could be leading to suboptimal outcomes in some patients.

“We will address this gap by establishing national expert guidelines for inherited genetic changes that are identified in childhood AML patients, and by improving diagnosis and prognostication of familial predisposition, leading to better treatments.”

CCB Research Fellow Dr Sarah Boyle has been awarded $199,883 from Cancer Australia and the Can Too Foundation to investigate a new way of tackling the spread of breast cancer and improving outcomes for patients.

Metastatic breast cancer is the most common cause of cancer-related related death in women and is helped by changes in the immediate environment that surrounds the breast cancer. This is influenced by rogue chemicals released from cancers as they grow.

“Breast cancer cells release chemicals that act on normal cells in their environment, which aid the cancer to spread to other organs. This project will focus on finding a way to block these chemicals that alter the environment, to stop breast cancer metastasis,” Dr Boyle says.

…………………………………………………………………………………………………………………………

Media contact: Candy Gibson M:  0434 605 142 E: [email protected]

Researchers:
Professor Michael Samuel E: [email protected]
Professor Richard D’Andrea E: [email protected]
Dr Sarah Boyle E: [email protected]

The source of this news is from University of South Australia

Popular in Research

1

1 day ago

Bringing Crises into Focus

2

6 days ago

Visionary cognitive neuroscientist Susan Courtney dies at 57

3

Jun 7, 2024

From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic

4

6 days ago

Tornados leave trail of destruction as 4 injured, hundreds of homes damaged

5

1 week ago

SV-faculty becomes partner in two new doctoral networks

Statement by NYU Spokesperson John Beckman about Situation on Greene St. Walkway

1 day ago

NATO chief says Ukraine can still win war despite Russian advances

1 day ago

Trump, Biden and CNN Prepare for a Hostile Debate (With Muted Mics)

1 day ago

The Resistance to a New Trump Administration Has Already Started

1 day ago

Fostering research, careers, and community in materials science

6 minutes from now

NYU’s Spring ITP/IMA Show Offers A Glimpse into the Future

1 day ago